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compared to a nine-month event rate of 32% in the corresponding
patients within GISSOC.
Undoubtedly, as stent designs improve, late complications will
become less frequent; thus, use of drug-eluting stents (3) in TOAT
and GISSOC could have resulted in fewer restenoses and reoc-
clusions. The use of post-stent clopidogrel and other thienopyri-
dines for only two weeks is validated and supported by Mishkel et
al. (4) and Berger et al. (5).
Unfortunately, Doppler color flow mapping was not a protocol
requirement in our study; therefore, quantitative assessment of
resting mitral regurgitation is incomplete. Nevertheless, because all
patients had single-vessel disease with left anterior descending
artery occlusion, the posterior papillary muscle is likely to have
been spared, making annular dilation the most probable mecha-
nism of mitral incompetence. We agree that the increased exercise
endurance observed in open-artery patients (despite increased left
ventricular volumes) is paradoxical, and likely to be mediated
through a placebo effect.
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Specificity of Noninvasive
Pacemaker Stress Echocardiography
in Diagnosis of Coronary Artery Disease
We read with great interest the recently published study by Picano
et al. (1) in the October 2, 2002, issue of JACC. The investigators
concluded that noninvasive pacemaker stress echocardiography is a
diagnostically efficient method for patients with a permanent
pacemaker and suspected or known coronary artery disease
(CAD).
Nevertheless, some concerns arise based on our experience and
from careful review of the published reports.
First, the main problem in detecting CAD in patients with
permanent ventricular pacing is the low specificity of noninvasive
techniques related to abnormalities of microvascular flow arising
from chronic functional and/or structural abnormalities induced by
abnormal ventricular excitation (2). We do not believe that the
study by Picano et al. (1) could solve this problem; the studied
group consisted of patients with a high prevalence of risk factors
for CAD (50%) and/or previous myocardial infarction (37%): it
was, therefore, an excellent way to assess the sensitivity of the
method, but not the specificity. In addition, 15 of 45 patients were
in AAI pacing mode, and even for the remaining patients we do
not know if there was partial or full ventricular excitation from the
pacemaker electrode during daily life or during the stress protocol.
We also do not know whether the studied group represents a total
population of patients with a pacemaker, as the manner of the
patients’ recruitment is unclear.
Second, the allegation that perfusion defects are more common
than wall motion abnormalities during stress in patients with
alterations of coronary flow reserve and normal epicardial coronary
arteries conflicts with the findings of a study by Tse et al. (3), who
observed wall motion abnormalities by radionuclide ventriculogra-
phy to occur in the same proportion of patients with permanent
ventricular stimulation and no significant CAD as did perfusion
defects detected by dipyridamole thallium myocardial scintigraphy.
Thus, the advantage of the stress echocardiogram remains in
question.
Third, given the deterioration of myocardial perfusion over time
that is observed in some studies (3,4), it is crucial to know the
mean duration of pacing, especially in patients without wall
motion abnormalities. Such data were not provided in the study by
Picano et al. (1).
In conclusion, although no one has doubt about the diagnostic
accuracy of the noninvasive pacemaker stress echocardiogram in
patients with AAI pacing mode, or, more generally, about the
sensitivity of the same method in detecting CAD, the specificity of
the method remains in doubt. Based on data currently available, a
specificity of 50% is the best we can expect from noninvasive
techniques (2–5), at least in patients with permanent ventricular
stimulation.
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Permanent ventricular pacing can induce an alteration in coronary
flow reserve independently of epicardial coronary artery stenosis.
Frequently, this may give rise to stress-induced perfusion abnor-
malities, which are “false positive” if we consider the anatomic,
angiographic gold standard and “true positive” if we consider the
functional gold standard of coronary flow reserve. This often
happens in patients with microvascular disease: hypertensives, left
ventricular hypertrophy, hypertrophic cardiomyopathies, diabetes,
syndrome X (1).
In diagnostic practice with stress imaging, not all patients follow
the reassuring imaging paradigm proposed by the classical ischemic
cascade. Indeed, the typical behavior of coronary microvascular
disease during stress testing is the frequent induction of chest pain,
ST-segment depression, and perfusion abnormalities without re-
gional or global wall motion changes (1). The high specificity of
pacemaker stress echocardiography in these patients is a particular
case of the generally higher specificity of wall function markers in
coronary microvascular disease (1). Left bundle branch block is
pathophysiologically germane to chronic ventricular pacing in that
a functional coronary microvascular disease can occur for an altered
sequence of ventricular activation, inducing abnormally increased
myocardial extravascular resistances in diastole (2). Vigna et al. (3)
reported 95% specificity of stress echocardiography and—in the
same patients—a specificity of 43% for sestamibi dipyridamole
perfusion imaging if reversible and/or fixed perfusion defects were
taken as positivity criteria in 37 patients with left bundle branch
block.
Previous studies described wall motion abnormalities by radio-
nuclide ventriculography to occur in patients with no significant
coronary artery disease. This is also not surprising. Wall mo-
tion—as evaluated by stress nuclear ventriculography—can be very
unreliable in patients with ventricular paced rhythm, and during
stress echocardiography, primary reliance is placed on regional wall
thickening—not motion. The unsurpassed spatial and temporal
resolution of stress echocardiography, and the need to rely on
systolic thickening to assess ischemia, explains the high specificity
of the procedure, which was observed regardless of the (very
variable) duration of pacing in patients with normal coronary
arteries and ventricular pacing.
Finally, to judge a priori that “a specificity of 50% is the best we
can expect from noninvasive techniques” on the basis of available
data on stress perfusion scintigraphy and radionuclide ventriculog-
raphy is perhaps a bit pessimistic. After all, however beautiful the
strategy, one should occasionally look at the results. With pace-
maker stress echocardiography, the diagnostic results are good,
especially for specificity. Moreover, the strategy (the underlying
rationale) is not so bad if we consider that: 1) not all diagnostic
ischemic markers are the same—and regional perfusion is not
synonymous with regional function (4); 2) not all techniques are
the same—and wall motion by nuclear ventriculography is not
synonymous with systolic thickening by two-dimensional echocar-
diography, especially with a ventricular paced rhythm (5); and 3)
that our monolithic view of the classic ischemic cascade should be
integrated with the awareness of the at least equally frequent
alternative ischemic cascade—linked to coronary microvascular
disease.
Eugenio Picano, MD, PhD
Instituto di Fisiologia Clinica CNR
Echocardiography Laboratory
Via Moruzzi 1
56100 Pisa, Italy
E-mail: picano@ifc.cnr.it
doi:10.1016/S0735-1097(02)02977-7
REFERENCES
1. Picano E, Palinkas A, Amyot R. Diagnosis of myocardial ischemia in
hypertensive patients. J Hypertens 2001;19:1177–83.
2. Skalidis EI, Kochiadakis GE, Koukouraki SI, Parthenakis FI, Karkavit-
sas NS, Vardas PE. Phasic coronary flow pattern and flow reserve in
patients with left bundle branch block and normal coronary arteries.
J Am Coll Cardiol 1999;33:1338–46.
3. Vigna C, Stanislao M, De Rito V, et al. Dipyridamole stress echocar-
diography vs. dipyridamole sestamibi scintigraphy for diagnosing coro-
nary artery disease in left bundle-branch block. Chest 2001;120:
1534–9.
4. Picano E. Stress echocardiography: a historical perspective. Am J Med
2003;114:126–30.
5. Picano E. Symptoms and signs of myocardial ischemia. In: Picano E,
editor. Stress Echocardiography. 4th ed. New York, NY: Springer
Verlag, 2003.
1069JACC Vol. 41, No. 6, 2003 Letters to the Editor
March 19, 2003:1065–9
